[Metastatic carcinoma of unknown origin]

Area of Science:

• Oncology
• Pathology

Context:

• Carcinomas of unknown primary site (CUP) constitute approximately 5% of all cancer diagnoses.
• CUP represents a heterogeneous group of metastatic epithelial malignancies lacking an identifiable primary tumor at diagnosis.
• These tumors are characterized by limited chemosensitivity and a generally poor prognosis, with a median survival of around six months.

Purpose:

• To outline diagnostic and therapeutic strategies for carcinomas of unknown primary site.
• To identify specific patient subgroups within CUP that may benefit from targeted therapies.
• To emphasize the role of prognostic factors in selecting appropriate management strategies.

Summary:

• The search for the primary tumor in CUP should focus on identifying distinct subgroups amenable to specific treatments.
• Key subgroups include those with squamous carcinoma in cervical lymph nodes, adenocarcinoma in axillary lymph nodes (women), peritoneal carcinomatosis (women), poorly differentiated midline carcinoma (young men), and neuroendocrine metastases.
• For patients not fitting these specific criteria, management should focus on symptomatic relief and potential chemotherapy.

Impact:

• This approach aims to improve treatment selection for CUP patients.
• Utilizing prognostic factors like performance status, histology, and alkaline phosphatase levels can aid in tailoring treatment plans.
• The ultimate goal is to preserve an optimal quality of life for patients diagnosed with carcinomas of unknown primary site.